EMIL SCHANDL, Ph.D. received a B.A. Degree from
the University of California, Santa Barbara (Analytical Biology), M.S.
from San Diego State University, San Diego, California (Biochemistry
and Enzymology) and a Ph.D. from the Institute of Molecular Biophysics,
Florida State University, Tallahassee (Molecular Genetics). He pursued
training in Nuclear Medicine and Clinical Laboratory Medicine at a Humana
Hospital in Hollywood, Florida.
He is a Clinical Laboratory Director in the specialties of Clinical
Chemistry, Hematology, Serology and Immunohematology in the states of
Florida and New York.
Dr. Schandl is a Fellow of the National Academy of Clinical Biochemistry,
certified by the American Society of Clinical Pathologists, registered
by the National Registry in Clinical Chemistry and past consultant to
the U.S. Environmental Protection Agency, Toxicology Department. He
has been a Professional Staff member of two acute care hospitals in
Hollywood, Florida. Dr. Schandl has published numerous articles in scientific
refereed journals and has written news articles on cancer, multiple
sclerosis, hyperactivity, anti-fluoridation of drinking water, etc.
Emil served on Florida Senator, Hon. Mack’s U.S. Senatorial Cancer
Advisory Committee for 10 years to advise on National cancer policies.
Since 1977, Dr. Schandl has been the Director of the Center for Metabolic
Disorders, CA Laboratory and currently American Metabolic Laboratories
and Metabolic Research, Inc., a not-for-profit, tax exempt research
organization. He is the inventor/designer of the blood tests Cancer
Profile©, (CA Profile©) for early detection and follow-up
of malignancies, and also of the Longevity Profile©, an expansion
of the Cancer Profile. These blood test panels can foretell cancer,
heart disease, bone loss and lack of longevity factors, years before
a diagnosis can be made by any other methods.
Presently Dr. Schandl is working on the development of cancer specific
antibodies and the applicability of stem cells in various diseased conditions.
He will speak on The Cancer Profile Blood Marker Test.